← Leaderboards
James Jason Collier
Lsu Pennington Biomedical Research Ctr
$2,453,535
Attributed
$2,509,785
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $467.7K · FY2018–24$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,509,785 · 4
By mechanism
R01$1,808,814 · 1
R21$435,580 · 1
R03$152,891 · 1
R56$112,500 · 1
Top collaborators
- Robert Charles Noland1 shared
Most similar at Lsu Pennington Biomedical Research Ctr
Same institution · by research overlap
- Susan J. Burke$1,076,069
Others in their field
Other Emerging Leaders on “Diabetes Mellitus”
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Bradley G Hammill · Duke University$15,773,864
- Francisco S Sy · University Of Nevada Las Vegas$11,999,607
- Gary Fanger · Rise Therapeutics, Llc$11,687,853
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$11,320,710
Research focus
Diabetes MellitusInsulinIn VivoMouse ModelEventMediatingDesignInsightIsletGeneticBeta CellCellsMetabolicFatty Acid Glycerol EstersResponseGlucocorticoidsGenesGenerationsPublishingAnabolismLipidsMolecularInsulin ResistanceAutomobile Driving
Grant awards (10)
SGK1 is a regulator of islet beta cell mass and secretory function$355,200
R01 · FY2024 · DK · contact PI
Mechanisms of glucocorticoid-induced metabolic dysfunction in skeletal muscle$112,500
R56 · FY2024 · DK
SGK1 is a regulator of islet beta cell mass and secretory function$370,000
R01 · FY2023 · DK · contact PI
SGK1 is a regulator of islet beta cell mass and secretory function$360,901
R01 · FY2022 · DK · contact PI
SGK1 is a regulator of islet beta cell mass and secretory function$352,713
R01 · FY2021 · DK · contact PI
Development of Mice with Conditional ICAM-1 Deletion$78,891
R03 · FY2021 · AI · contact PI
SGK1 is a regulator of islet beta cell mass and secretory function$370,000
R01 · FY2020 · DK · contact PI
Development of Mice with Conditional ICAM-1 Deletion$74,000
R03 · FY2020 · AI · contact PI
A Unique Receptor Agonist Approach for Type 1 Diabetes Prevention$193,101
R21 · FY2019 · AI · contact PI
A Unique Receptor Agonist Approach for Type 1 Diabetes Prevention$242,479
R21 · FY2018 · AI · contact PI